MCP1 haplotypes associated with protection from pulmonary tuberculosis

Area of Science:

• Immunogenetics
• Molecular Biology
• Infectious Diseases

Background:

• Monocyte chemoattractant protein 1 (MCP-1) is crucial for immune cell recruitment in inflammatory responses.
• Previous studies suggested conflicting associations between MCP-1 gene variants and tuberculosis (TB) resistance in different populations.
• Investigating these discrepancies is essential to identify causal genetic factors influencing TB susceptibility.

Purpose of the Study:

• To genetically and functionally investigate the monocyte chemoattractant protein 1 (MCP-1) gene for causal variants or haplotypes related to TB resistance.
• To resolve inconsistencies in previous findings regarding MCP-1 gene associations with TB in diverse ethnic groups.

Main Methods:

• Case-control study design involving a Ghanaian population.
• Genotyping of specific MCP-1 gene promoter and intronic variants (-362C, -2581G, int1del554-567).
• Luciferase reporter gene assay to assess the functional impact of identified variants on MCP-1 gene expression.

Main Results:

• A 14 base-pair deletion in the first MCP-1 intron (int1del554-567) showed strong association with protection against pulmonary TB (OR=0.84).
• A specific haplotype (-2581G/-362C/int1del554-567) conferred even greater protection against TB than the -362C variant alone (OR=0.78).
• Luciferase assays confirmed that MCP-1 variants, particularly the protective haplotype, significantly reduce MCP-1 gene expression.

Conclusions:

• The identified haplotype combination (-2581G/-362C/int1del554-567) provides substantial protection against pulmonary TB in the studied Ghanaian population.
• These findings highlight the role of MCP-1 genetic variations in modulating TB risk.
• The study underscores the importance of considering both genetic and functional analyses to elucidate complex disease associations.